These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5821421)

  • 21. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
    Greene CE; Meriwether E
    Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The viscocoagulography, a new device for objective registration of blood coagulation].
    Zeschke G; Gnüchtel U
    Z Gesamte Inn Med; 1968 May; 23(10):297-305. PubMed ID: 5701144
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of oxygen baths at different concentrations on the blood coagulating mechanisms in patients with circulatory encephalopathy].
    Musaev AV; Rakhmani SA; Nurieva LR
    Vopr Kurortol Fizioter Lech Fiz Kult; 1994; (6):18-21. PubMed ID: 7762201
    [No Abstract]   [Full Text] [Related]  

  • 24. [Action of venom of the central Asian cobra (Naja oxiana eich.) on the blood-coagulating system].
    Mitel'man LSh
    Biull Eksp Biol Med; 1966 Sep; 62(9):69-71. PubMed ID: 6012423
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of dibunol on plasma, erythrocyte and thrombocyte coagulating and fibrinolytic activity].
    Gol'denberg IuM
    Fiziol Zh (1978); 1980; 26(5):695-7. PubMed ID: 7428973
    [No Abstract]   [Full Text] [Related]  

  • 26. [Anticoagulant treatment with heparin].
    Langer B; Wolosker M; Albers MT
    Rev Paul Med; 1982; 99(1):31-2. PubMed ID: 7146741
    [No Abstract]   [Full Text] [Related]  

  • 27. [Coagulating system of the lymph and blood in experimental apical periodontitis].
    Iaroshenko IF; Temkin ES; Pupysheva GI
    Stomatologiia (Mosk); 1987; 66(1):18-9. PubMed ID: 3470981
    [No Abstract]   [Full Text] [Related]  

  • 28. [Does heparin exert any influence on the secretion of tissue blood coagulating factors from vascular walls?].
    Mishchenko VP
    Patol Fiziol Eksp Ter; 1970; 14(1):45-9. PubMed ID: 5453784
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of oxalic and malonic acids on the clotting mechanism of dogs.
    Dooley KL; Zimmerman HE
    J Am Vet Med Assoc; 1971 Feb; 158(3):346-8. PubMed ID: 5545547
    [No Abstract]   [Full Text] [Related]  

  • 30. [Coagulation-active phospholipids. Contribution to the coagulation-physiological and chemical characterization of thrombocyte and placental extracts rich on phosphatides].
    Trobisch H; Schwinn H
    Med Welt; 1974 Oct; 25(40):1604-8. PubMed ID: 4444498
    [No Abstract]   [Full Text] [Related]  

  • 31. [The pathogenesis of blood coagulation disorders following rapid intravenous administration of placental extract].
    Skipetrov VP
    Patol Fiziol Eksp Ter; 1968; 12(3):67-8. PubMed ID: 5747737
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of UDMH on blood coagulation, the blood-aqueous barrier and the cornea.
    Smith EB; Castaneda FA
    Aerosp Med; 1970 Nov; 41(11):1240-3. PubMed ID: 5490160
    [No Abstract]   [Full Text] [Related]  

  • 33. [Blood clot retraction and its changes under the influence of some hemostatic agents].
    Akopov IE; Iadrova VM
    Biull Eksp Biol Med; 1966 Aug; 62(8):64-7. PubMed ID: 6005478
    [No Abstract]   [Full Text] [Related]  

  • 34. [Changes in the blood coagulation in dogs following intravenous injection of thromboplastin].
    Rusakova GP
    Patol Fiziol Eksp Ter; 1965; 9(5):82-4. PubMed ID: 5877806
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the mechanism of action of protamine-sulfate on some indices of blood coagulation system].
    Skipetrov VP
    Farmakol Toksikol; 1966; 29(2):188-92. PubMed ID: 6000344
    [No Abstract]   [Full Text] [Related]  

  • 36. [Research on the neurohumoral regulation of circulation. Inhibition of the hypertensive actvity of placental protein extracts by antirenin immune serums].
    Tallarida G; Cassone R; Semprini A; Baldoni F
    Boll Soc Ital Biol Sper; 1971 Sep; 47(17):508-12. PubMed ID: 4400905
    [No Abstract]   [Full Text] [Related]  

  • 37. Activated coagulation time in monitoring heparinized dogs.
    Green RA
    Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of i.v. and oral administration of heparinoids G31150, G31150-A and of nitrilotriacetic acid on blood coagulation.
    Jarrett CL; Jaques LB
    Thromb Diath Haemorrh; 1971; 25(1):187-200. PubMed ID: 4102832
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative evaluation of systemic coagulants in dogs.
    Klemm WR; Bolton GR
    Arzneimittelforschung; 1967 Dec; 17(12):1573-4. PubMed ID: 5632801
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of unprocessed placental extracts from term pregnancies on fibrinolysis (euglobulin test)].
    Slunský R; Adamcová M
    Zentralbl Gynakol; 1968 Jul; 90(29):995-9. PubMed ID: 5691243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.